Scientist, Advanced Genomics Applications in QIAGEN
QIAGEN enhances its portfolio with several PCR-based assay panels covering entire biological pathways and diseases, thereby strengthening its offering for pharmaceutical research. QIAGEN acquires DxS Ltd., giving the company a leadership position in personalized healthcare.
Post: Scientist, Advanced Genomics Applications



